1. Home
  2. IMRN vs HCAI Comparison

IMRN vs HCAI Comparison

Compare IMRN & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.97

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$0.35

Market Cap

11.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
HCAI
Founded
1994
2004
Country
Australia
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
11.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
IMRN
HCAI
Price
$0.97
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.4K
102.4K
Earning Date
02-27-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
$4,777,422.00
$19,176,987.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$97.31
Revenue Growth
48.63
N/A
52 Week Low
$0.68
$0.28
52 Week High
$2.39
$10.97

Technical Indicators

Market Signals
Indicator
IMRN
HCAI
Relative Strength Index (RSI) 46.08 54.71
Support Level $0.93 $0.32
Resistance Level $1.05 $0.36
Average True Range (ATR) 0.10 0.02
MACD 0.02 0.01
Stochastic Oscillator 37.43 98.18

Price Performance

Historical Comparison
IMRN
HCAI

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

Share on Social Networks: